Table 1 General characteristics of the approaches for prioritizing guideline topics
From: Prioritization approaches in the development of health practice guidelines: a systematic review
Paper | Lead entity | Target audience | Field (specific domain) | Focus of prioritization | Type of guideline development |
|---|---|---|---|---|---|
Battista, 1995 [12] | Independent researchers | Canadian guideline developing groups | Clinical | Topics | De novo |
Field, 1995 [13] | Institute of Medicine | Agency for Health Care Policy and Research | Clinical | Topics | De novo |
McClarey, 1999 [14] | Royal College of Nursing (RCN) | RCN guideline developers | Clinical, nursing | Topics (e.g., hyperplasia, colon cancer, breast cancer, wound care, etc.) | De novo |
Oxman, 2006 [15] | WHO Advisory Committee on Health Research | WHO entities developing guidelines | Health care | Topics or interventions | De novo |
Ketola, 2007 [16] | ‘Current Care’ | Guideline developers | Clinical | Topics (e.g., benign prostatic hypertrophy, brain injuries in adults, atrial fibrillation, cataract, etc.) | De novo |
Reveiz, 2010 [17] | Independent researchers | Guideline developers within developing countries | Clinical | Topics | De novo |
Atkins, 2012 [18] | Independent researchers | Guideline developers in respiratory diseases | Clinical, respiratory diseases | Topics | De novo |
Schünemann, 2014 [8] | Independent researchers | Guideline developers | Clinical, Public health and Health systems | Topics | De novo |
Reddy, 2014 [19] | Independent researchers | National Institute for Health and Care Excellence (NICE) | Public health | Topic (e.g., sickle cell screening, substance misuse, water fluoridation, etc.) | De novo |
Mounesan, 2016 [20] | Tehran University of Medical Sciences | Guideline developers | Clinical, family medicine | Topics (e.g., anemia, osteoporosis, indigestion/dyspepsia, pneumonia, etc.) | De novo |